News
1mon
GlobalData on MSNHutchmed concludes enrolment in Phase II trial of fanregratinib for IHCCAbnormal alterations in the FGFR gene are stated to play a central role in driving tumour cell proliferation in various solid ...
FGFRi are a safe and effective treatment strategy for patients with advanced solid tumors, in particular in the presence of FGFR rearrangements and/or gene amplifications. In contrast, mutations are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results